National Health Commission of the People’s Republic of China [to 12 Jun 2021]
June 11: Daily briefing on novel coronavirus cases in China
On June 10, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 22 new cases of confirmed infections.
21 COVID-19 vaccines enter clinical trials in China
BEIJING — China has witnessed 21 COVID-19 vaccines enter clinical trials, an official with the National Health Commission (NHC) said on June 6.
far, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, according to Zeng Yixin, deputy head of the NHC.
A total of eight COVID-19 vaccines have been approved for phase III clinical trial overseas, and one messenger RNA (mRNA) COVID-19 vaccine met the ethical requirements for phase III clinical trial overseas, Zeng said.
National Medical Products Administration – PRC [to 12 Jun 2021]
China reaches 800-million-dose milestone in vaccination campaign
The National Health Commission said it took 25 days to reach 200 million doses from 100 million; 16 days to 300 million and only six days to 600 million from 500 million, showing increased injection efficiency.